Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents. Its enantiomerically pure structure makes it valuable for creating selective serotonin reuptake inhibitors (SSRIs) and other neuroactive compounds. The presence of both bromo and fluoro substituents allows for further functionalization via cross-coupling reactions, enabling the construction of complex molecular architectures in drug discovery. Commonly employed in asymmetric synthesis routes where the amine group serves as a handle for amide or sulfonamide formation, enhancing pharmacokinetic properties in final drug candidates.